Mark White

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .

COM902, a novel therapeutic antibody targeting TIGIT augments anti-tumor T cell function in combination with PVRIG or PD-1 pathway blockade

E. Ophir, A. Drake, Spencer C. Liang, 2021, Cancer Immunology, Immunotherapy.

PVRIG and PVRL2 Are Induced in Cancer and Inhibit CD8+ T-cell Function

J. Taube, I. Shih, O. Levy, 2019, Cancer Immunology Research.

Discovery of COM701, a therapeutic antibody targeting the novel immune checkpoint PVRIG, for the treatment of cancer.

O. Levy, L. Dassa, E. Ophir, 2017 .

31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): late breaking abstracts

Amanda R. Campbell, F. Lund-Johansen, Yair Benita, 2016 .